Cumberland Pharmaceuticals Inc. (CPIX) - Operating Margin

Corporate emblem and logo of Cumberland Pharma (CPIX)

Generic pressure and marketing expenses are weighing on Cumberland Pharmaceuticals (CPIX) profitability, causing the operating margin to exhibit volatility, with the -36.70 mark reflecting the current state. Growth is driven by hospital sales of Vaprisol and Vibativ. Simultaneously, Cumberland Pharmaceuticals (CPIX) is implementing eco-friendly waste disposal and optimizing laboratory energy costs while maintaining high safety standards in risk management.

Cumberland Pharmaceuticals Inc. (CPIX): Operating Profit Rate from 07/04/2022 to 11/20/2026

Analytical breakdowns and data insights for company cumberlandpharma.com (CPIX)

- share price and consensus valuation forecast:
General company analysis:Cumberland Pharmaceuticals, CPIX
Finished products of Cumberland Pharmaceuticals

To select high-quality assets, an investor must evaluate the efficiency of profit generation from core operations before accounting for debt loads and tax obligations. This metric measures the share of operating income in revenue, which for Cumberland Pharmaceuticals (CPIX) confirms the monetization of high physician trust in critical drugs, reflecting the brand's financial stability through its target operating margin.

Competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.